George I. Papakostas, MD
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Educational Activity
Augmentation and Adjunctive Strategies for Inadequate Response in MDD
May 12, 2020
When a patient with major depressive disorder isn't responding to antidepressant treatment, what are your next moves? In this activity, learn from the experts about augmentation and adjunctive strategies.
Educational Activity
Recognizing Inadequate Response in Patients With MDD
May 5, 2020
Can you recognize inadequate antidepressant response? How does it differ from treatment-resistant depression? In this activity, experts discuss definitions of response as well as residual symptoms seen with inadequate...
Review Article
Treatment-Resistant Depression Definition and Staging
June 4, 2019
To optimize treatment choices for patients with treatment-resistant depression (TRD), TRD should be defined accurately and unambiguously. This review examines extant descriptions and staging models of TRD and posits...
Original Research
Ziprasidone Augmentation of Escitalopram for Cognition
July 25, 2017
Cognitive deficits are common in depression, but studies suggest that cognitive dysfunction is difficult to treat with antidepressants. Can adding an atypical antipsychotic medication to antidepressant treatment help lessen...
